In a study of human high-grade ductal carcinoma in situ (DCIS), a precursor lesion of invasive ductal carcinoma (IDC), the p53 pathway was inactivated in all DCIS specimens [11]. This evidence concerns the gene TP53 and ductal breast carcinoma in situ.